Inhibition of glycogen synthase kinase-3

18Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

There are two homologous forms of glycogen synthase kinase (GSK)-3, GSK-3α and GSK-3β, which play overlapping roles in the regulation of Wnt, Hedgehog, and insulin pathways, as well as the activation of nuclear factor (NF)-kB-mediated gene transcription. These signaling pathways regulate gene transcription, cell cycle, apoptosis, inflammation, glucose metabolism, stem-cell renewal, and differentiation. More than 50 GSK-3 inhibitors representing a wide range of chemical structures have already been identified, and their utility in the treatment of type II diabetes mellitus, Alzheimer's disease, bipolar diseases, cancer, and other human pathologies is currently being investigated. Here, we discuss two methods of GSK-3 inhibition, which can be used to determine the involvement of GSK-3 in a cellular process of interest. © 2009 Humana Press.

Cite

CITATION STYLE

APA

Ougolkov, A. V., & Billadeau, D. D. (2008). Inhibition of glycogen synthase kinase-3. Methods in Molecular Biology, 468, 67–75. https://doi.org/10.1007/978-1-59745-249-6_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free